Pemafibrate is suitable for specific patients with dyslipidemia, but there are clear contraindications for the population. The following provid...
When Pemafibrate is used as a lipid-lowering medication, various adverse reactions may occur, including common gastrointestinal reactions, live...
Vericiguat is suitable for specific cardiovascular disease patients, but strict evaluation of contraindications is required. This drug is mainl...
Vericiguat is a soluble guanylate cyclase (sGC) stimulant that improves ejection fraction in heart failure patients by enhancing the NO sgC cGM...
Brensoacatib regulates neutrophil activation by specifically inhibiting DPP1 enzyme, thereby reducing the release of inflammatory mediators and...
Brensoacatib is a novel dipeptidyl peptidase 1 (DPP1) inhibitor that provides an innovative treatment option for patients with bronchiectasis. ...
Daclatasvir, as an NS5A inhibitor, is an important drug for treating hepatitis C. It is necessary to strictly follow the medication guidelines ...
As an antiviral drug for hepatitis C, the use of Daclatasvir requires special attention to drug interaction risks and liver function monitoring...
As a compound antihypertensive drug, the use of valsartan and amlodipine tablets (Atedio) in special populations requires special attention to ...
As a compound antihypertensive drug, the side effects of valsartan and amlodipine tablets mainly involve cardiovascular system, metabolic abn...